Evaluation of Non-intensive Care Unit-Acquired 
Sepsis and Septic Shock Patients in Intensive Care 
Unit Outcomes

Gündoğan, Kürşat; onuk, sevda; BULUT, Kadir; Sungur, Murat; Sipahioğlu, Hilal; Dirik, Hasan

doi:10.14744/etd.2021.47427

Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes

Hilal SİPAHİOĞLU, (Erciyes Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Yoğun Bakım Ünitesi, Kayseri, Türkiye)

Sevda ONUK, (Erciyes Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Yoğun Bakım Ünitesi, Kayseri, Türkiye)

Hasan DİRİK, (Erciyes Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Yoğun Bakım Ünitesi, Kayseri, Türkiye)

Kadir BULUT, (Erciyes Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Yoğun Bakım Ünitesi, Kayseri, Türkiye)

Murat SUNGUR, (Erciyes Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Yoğun Bakım Ünitesi, Kayseri, Türkiye)

Kürşat GÜNDOĞAN (Erciyes Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Yoğun Bakım Ünitesi, Kayseri, Türkiye)

Erciyes Medical Journal

2 0

Yıl: 2022 Cilt: 44 Sayı: 2 Sayfa Aralığı: 161 - 166 Metin Dili: İngilizce DOI: 10.14744/etd.2021.47427 İndeks Tarihi: 05-07-2022

Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes

Öz:

Objective: Sepsis is a clinical condition that requires urgent treatment. Most patients with sepsis require intensive care. There is a high mortality rate. The primary aim of the present study was to examine risk factors for mortality in patients with sepsis or septic shock in a medical intensive care unit (ICU). The secondary objective was to analyze the demographic and clinical characteristics of these patients. Materials and Methods: This prospective study was conducted in a medical ICU. Patients diagnosed with sepsis according to the international consensus definition (Sepsis-3) and requiring ICU treatment were included in the study. Demographic and clinical characteristics were recorded and analyzed. Results: A total of 134 patients with sepsis were enrolled in the study. The mean age was 60±18 years and 49% were male. The most frequent reasons for admission to the ICU were respiratory failure (45.5%) and shock (44%). Gram-negative bacteria were present in 48%, Gram-positive bacteria in 15%, fungus in 8%, and there was no culture positivity in 29% of the patients. The in-hospital mortality rate was 51%. The need for vasopressor drugs (odds ratio [OR]: 4.612, 95% confidence interval [CI]: 1.273–16.781) or mechanical ventilation (OR: 25.312, 95% CI: 4.225–151.852) was an independent risk factor for mortality. Conclusion: Patients treated in the ICU for sepsis or septic shock had a high mortality rate. The need for vasopressor drugs or mechanical ventilation was an independent risk factor for mortality.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Prescott HC, Osterholzer JJ, Langa KM, Angus DC, Iwashyna TJ. Late mortality after sepsis: propensity matched cohort study. BMJ 2016; 353: i2375.
2. Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med 2010; 38(5): 1276–83.
3. Weycker D, Akhras KS, Edelsberg J, Angus DC, Oster G. Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 2003; 31(9): 2316–23.
4. Wunsch H, Angus DC, Harrison DA, Linde-Zwirble WT, Rowan KM. Comparison of medical admissions to intensive care units in the United States and United Kingdom. Am J Respir Crit Care Med 2011; 183(12): 1666–73.
5. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al; Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34(2): 344–53.
6. Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Crit Care Med 2014; 42(3): 625–31.
7. Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al; CDC Prevention Epicenter Program. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA 2017; 318(13): 1241–9.
8. Rhee C, Kadri S, Huang SS, Murphy MV, Li L, Platt R, et al. Objective sepsis surveillance using electronic clinical data. Infect Control Hosp Epidemiol 2016; 37(2): 163–71.
9. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med 2017; 45(3): 486–552.
10. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012; 120(4) :c179–84.
11. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012; 38(10): 1573–82.
12. Bracht H, Hafner S, Weiss M. Sepsis Update: Definition and epidemiology. [Article in German]. Anasthesiol Intensivmed Notfallmed Schmerzther 2019; 54(1): 10–20.
13. Vallés J, Palomar M, Alvárez-Lerma F, Rello J, Blanco A, GarnachoMontero J, et al; GTEI/SEMICYUC Working Group on Bacteremia. Evolution over a 15-year period of clinical characteristics and outcomes of critically ill patients with community-acquired bacteremia. Crit Care Med 2013; 41(1): 76–83.
14. Valles J, Fontanals D, Oliva JC, Martínez M, Navas A, Mesquida J, et al. Trends in the incidence and mortality of patients with communityacquired septic shock 2003-2016. J Crit Care 2019; 53: 46–52.
15. Lu J, Wei Z, Jiang H, Cheng L, Chen Q, Chen M, et al. Lactate dehydrogenase is associated with 28-day mortality in patients with sepsis: a retrospective observational study. J Surg Res. 2018; 228: 314–21.
16. Zhang Z, Bokhari F, Guo Y, Goyal H. Prolonged length of stay in the emergency department and increased risk of hospital mortality in patients with sepsis requiring ICU admission. Emerg Med J 2019; 36(2): 82–7.
17. Westphal GA, Pereira AB, Fachin SM, Barreto ACC, Bornschein ACGJ, Caldeira Filho M, et al. Characteristics and outcomes of patients with community-acquired and hospital-acquired sepsis. Rev Bras Ter Intensiva 2019; 31(1): 71–8.
18. Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 2017; 376(23): 2235–44.
19. Yang H, Wang W, Li Y, Tian L, Jing M, Hu Y. Application effect of 1-hour bundle in the treatment of patients with sepsis. [Article in Chinese]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2019; 31(9): 1087–90.
20. SepNet Critical Care Trials Group. Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med 2016; 42(12): 1980–9.
21. Gundogan K, Akbudak IH, Bulut K, Temel S, Sungur M, Guven M, et al. Thiamin status in adults receiving chronic diuretic therapy prior to admission to a medical intensive care unit: A pilot study. Nutr Clin Pract 2019; 34(4): 565–71.
22. Khwannimit B, Bhurayanontachai R, Vattanavanit V. Comparison of the performance of SOFA, qSOFA and SIRS for predicting mortality and organ failure among sepsis patients admitted to the intensive care unit in a middle-income country. J Crit Care 2018; 44: 156–60.
23. Liu Z, Meng Z, Li Y, Zhao J, Wu S, Gou S, et al. Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with Sepsis. Scand J Trauma Resusc Emerg Med 2019; 27(1): 51.
24. Karakike E, Kyriazopoulou E, Tsangaris I, Routsi C, Vincent JL, Giamarellos-Bourboulis EJ. The early change of SOFA score as a prognostic marker of 28-day sepsis mortality: analysis through a derivation and a validation cohort. Crit Care 2019; 23(1): 387.
25. Zhang Q, Fei Y, Jiang L. Risk factors for mortality in intensive care unit patients with sepsis combined with acute kidney injury after continuous renal replacement therapy: secondary analysis of the data from a multicenter observational study. [Article in Chinese]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2019; 31(2): 155–9.
26. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al; EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302(21): 2323–9.
27. Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, et al; CRICS-TRIGGERSEP Network. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med 2018; 378(9): 809–18.
28. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358(2): 111–24.
29. Fleischmann-Struzek C, Mellhammar L, Rose N, Cassini A, Rudd KE, Schlattmann P, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med 2020; 46(8): 1552–62.
30. Markwart R, Saito H, Harder T, Tomczyk S, Cassini A, Fleischmann-Struzek C, et al. Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis. Intensive Care Med 2020; 46(8): 1536–51.

APA	Sipahioğlu H, onuk s, Dirik H, BULUT K, Sungur M, Gündoğan K (2022). Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes. , 161 - 166. 10.14744/etd.2021.47427
Chicago	Sipahioğlu Hilal,onuk sevda,Dirik Hasan,BULUT Kadir,Sungur Murat,Gündoğan Kürşat Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes. (2022): 161 - 166. 10.14744/etd.2021.47427
MLA	Sipahioğlu Hilal,onuk sevda,Dirik Hasan,BULUT Kadir,Sungur Murat,Gündoğan Kürşat Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes. , 2022, ss.161 - 166. 10.14744/etd.2021.47427
AMA	Sipahioğlu H,onuk s,Dirik H,BULUT K,Sungur M,Gündoğan K Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes. . 2022; 161 - 166. 10.14744/etd.2021.47427
Vancouver	Sipahioğlu H,onuk s,Dirik H,BULUT K,Sungur M,Gündoğan K Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes. . 2022; 161 - 166. 10.14744/etd.2021.47427
IEEE	Sipahioğlu H,onuk s,Dirik H,BULUT K,Sungur M,Gündoğan K "Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes." , ss.161 - 166, 2022. 10.14744/etd.2021.47427
ISNAD	Sipahioğlu, Hilal vd. "Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes". (2022), 161-166. https://doi.org/10.14744/etd.2021.47427

APA	Sipahioğlu H, onuk s, Dirik H, BULUT K, Sungur M, Gündoğan K (2022). Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes. Erciyes Medical Journal, 44(2), 161 - 166. 10.14744/etd.2021.47427
Chicago	Sipahioğlu Hilal,onuk sevda,Dirik Hasan,BULUT Kadir,Sungur Murat,Gündoğan Kürşat Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes. Erciyes Medical Journal 44, no.2 (2022): 161 - 166. 10.14744/etd.2021.47427
MLA	Sipahioğlu Hilal,onuk sevda,Dirik Hasan,BULUT Kadir,Sungur Murat,Gündoğan Kürşat Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes. Erciyes Medical Journal, vol.44, no.2, 2022, ss.161 - 166. 10.14744/etd.2021.47427
AMA	Sipahioğlu H,onuk s,Dirik H,BULUT K,Sungur M,Gündoğan K Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes. Erciyes Medical Journal. 2022; 44(2): 161 - 166. 10.14744/etd.2021.47427
Vancouver	Sipahioğlu H,onuk s,Dirik H,BULUT K,Sungur M,Gündoğan K Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes. Erciyes Medical Journal. 2022; 44(2): 161 - 166. 10.14744/etd.2021.47427
IEEE	Sipahioğlu H,onuk s,Dirik H,BULUT K,Sungur M,Gündoğan K "Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes." Erciyes Medical Journal, 44, ss.161 - 166, 2022. 10.14744/etd.2021.47427
ISNAD	Sipahioğlu, Hilal vd. "Evaluation of Non-intensive Care Unit-Acquired Sepsis and Septic Shock Patients in Intensive Care Unit Outcomes". Erciyes Medical Journal 44/2 (2022), 161-166. https://doi.org/10.14744/etd.2021.47427